News About: Pharm. Industry
Green Cross wins largest blood product tender ever
Green Cross has drawn the largest exports of blood product ever.
Green Cross(CEO Eun-Cheol Huh) announced on the 22nd that the company obtained an order of IV-Globulin SN(IVIG-SN) worth of USD 42.9 million(KRW 47 bil...
How much did listed pharmaceutical companies spend on SG&A expenses?
This year, the increase of collective selling, general & administrative(SG&A) expenses by the 3rd quarter of the year on average was 20 times higher in the KOSDAQ market than the one in the KOSPI. When it comes to the...
Pharmaceutical companies’ concerns over ‘Financial Gain & Expenditure Report’ even before it starts
While being active in preparing for the ‘Financial Gain & Expenditure Report’ which will be implemented from 1 January 2018, pharmaceutical companies have encountered a new concern.
When the report became obligated, ...
Distribution industry opposes to pharmaceutical company sending back returned medicines without shipping record
The pharmaceutical distribution industry has strong opposed to pharmaceutical companies which cut off returning stored medicines in a self-interested fashion in regards to the serial number system.
According to the i...
Where are biotech companies at in ‘cutting-edge biologic development’
Under the ‘Global High-Tech Biotechnology Development Project’ that the Ministry of Science and ICT and the Ministry of Health and Welfare have carried out as a part of the plan to raise world-class biotech companies,...
6 CEOs in pharma industry received more than KRW 500 million wages for the past 9 months
Wages for 6 CEOs in the pharmaceutical industry, including Boryung Pharm Chairman Eun-Sun Kim, reportedly exceeded KRW 500 million for the past 9 months.
Yakup Shinmoon(www.yakup.com) analyzed 2017 3rd quarter repor...
Yuhan Corporation’s drive to diversify business in cosmetic market
The top sales pharmaceutical company of Korea, Yuhan Corporation will diversify its business.
According to Yuhan Corporation, the company founded a cosmetic company as a way to diversity its business, planning to agg...
Listed pharmas to cut advertising expenses as a way to control SG&A expenses
Pharmaceutical companies have reportedly cut advertising expenses significantly as a method to control selling, general and administrative expenses.
In addition, while the top sales pharmaceutical companies have redu...
Samsung Bioepis first acquires approval of Herceptin biosimilar in Europe
Samsung Bioepis(CEO/President Han-Seung Ko) has become the first to acquire sales approval of breast cancer biosimilar in Europe, away from other multinational pharmaceutical companies.
On the 20th(local time), Samsu...
Yuhan Corporation works on a new business for health functional foods
Yuhan Corporation(CEO Jung-Hee Lee) will expand new businesses through developing special health functional foods, such as antler products.
Yuhan Corporation signed a memorandum of understanding with the Designers In...
